Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

Bay Area's Arcus Biosciences Scores $107M, Initiates Two Clinical Trials

  • Post author:Sam
  • Post published:November 12, 2017
  • Post category:BioPharma

Now totaling $227M, Arcus Biosciences announced it had closed a $107M Series C financing. Source: BioSpace

Continue ReadingBay Area's Arcus Biosciences Scores $107M, Initiates Two Clinical Trials

Lessons Learned: One-Time Leader Juno Uses Deaths to Create a Better CAR-T Formula

  • Post author:Sam
  • Post published:November 12, 2017
  • Post category:BioPharma

Neurotoxicity killed JCAR015 right along with 5 patients in the lead pivotal study, derailing Juno Therapeutics. Source: BioSpace

Continue ReadingLessons Learned: One-Time Leader Juno Uses Deaths to Create a Better CAR-T Formula

Argos Surges on Positive Phase III Kidney Cancer Data

  • Post author:Sam
  • Post published:November 12, 2017
  • Post category:BioPharma

Investors in beleaguered Argos are smiling this morning after the company announced some positive interim data for its Phase III kidney cancer drug, Rocapuldencel-T - a trial that some said…

Continue ReadingArgos Surges on Positive Phase III Kidney Cancer Data

Valeant Providing Reporters With an Earnings Metric the SEC Ordered it to Stop Using

  • Post author:Sam
  • Post published:November 9, 2017
  • Post category:BioPharma

Valeant is not the only company to recently push reporters to defy the SEC’s orders. Source: BioSpace

Continue ReadingValeant Providing Reporters With an Earnings Metric the SEC Ordered it to Stop Using

Former Eli Lilly Exec Expected to be Named Trump's HHS Secretary

  • Post author:Sam
  • Post published:November 9, 2017
  • Post category:BioPharma

President Donald Trump could be close to naming former Eli Lilly exec Alex Azar as new Secretary of HHS, according to reports. Source: BioSpace

Continue ReadingFormer Eli Lilly Exec Expected to be Named Trump's HHS Secretary

How GlaxoSmithKline Lost Nearly $10B in October

  • Post author:Sam
  • Post published:November 9, 2017
  • Post category:BioPharma

Could GlaxoSmithKline's industry-leading dividend be at risk? Source: BioSpace

Continue ReadingHow GlaxoSmithKline Lost Nearly $10B in October

Sunovion Announces FDA Acceptance for Review of New Drug Application for Dasotraline for the Trea…

  • Post author:Sam
  • Post published:November 9, 2017
  • Post category:BioPharma

The NDA submission is supported by multiple placebo-controlled safety and efficacy studies, as well as two long-term studies that assessed the safety of dasotraline in people with ADHD for up…

Continue ReadingSunovion Announces FDA Acceptance for Review of New Drug Application for Dasotraline for the Trea…

Global Med Device Leader Anthrex Reveals Big Expansion Plans

  • Post author:Sam
  • Post published:November 9, 2017
  • Post category:BioPharma

Less than one month after announcing plans for construction of a South Carolina manufacturing facility, Arthrex announces its plans for the expansion of its global headquarters in Florida. Source: BioSpace

Continue ReadingGlobal Med Device Leader Anthrex Reveals Big Expansion Plans

Booming Abeona Plans to Hire Dozens of New Employees in Expansion

  • Post author:Sam
  • Post published:November 9, 2017
  • Post category:BioPharma

Abeona Therapeutics has plans to expand its facilities and hire an additional 25 to 40 employees. Source: BioSpace

Continue ReadingBooming Abeona Plans to Hire Dozens of New Employees in Expansion

IM Therapeutics Spins Out of University of Colorado to Focus on Type 1 Diabetes

  • Post author:Sam
  • Post published:November 9, 2017
  • Post category:BioPharma

ImmunoMolecular Therapeputics officially launched yesterday. Source: BioSpace

Continue ReadingIM Therapeutics Spins Out of University of Colorado to Focus on Type 1 Diabetes
  • Go to the previous page
  • 1
  • …
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • …
  • 288
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.